Canada -
English -
Health Canada
ziextenzo solution
sandoz canada incorporated - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg - hematopoietic agents
Canada -
English -
Health Canada
lapelga solution
apotex inc - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg - hematopoietic agents
Canada -
English -
Health Canada
lapelga solution
apotex inc - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg
Canada -
English -
Health Canada
neulasta solution
amgen canada inc - pegfilgrastim - solution - 10mg - pegfilgrastim 10mg - hematopoietic agents
Australia -
English -
Department of Health (Therapeutic Goods Administration)
neutropeg pegfilgrastim 6 mg/0.6 ml solution for injection pre-filled syringe
accord healthcare pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections - for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
filpegla pegfilgrastim 6 mg/0.6 ml solution for injection syringe
cipla australia pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sorbitol; polysorbate 20; sodium hydroxide; glacial acetic acid; water for injections - filpegla is indicated for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.
Australia -
English -
Department of Health (Therapeutic Goods Administration)
neulasta pegfilgrastim rbe 6mg/0.6ml injection syringe with stelmi needle shield
amgen australia pty ltd - pegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: sodium; water for injections; sorbitol; polysorbate 20; acetate - for the treatment of cancer patients following chemotherapy to decrease the duration of severe neutropenia, and so reduce the incidence of infection, as manifested by febrile neutropenia.
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
fulphila 6 mg 0.6 ml solution for injection
biocon sdn bhd - pegfilgrastim -
Singapore -
English -
HSA (Health Sciences Authority)
lonquex solution for injection in pre-filled syringe 6mg0.6ml
teva pharmaceutical investments singapore pte. ltd. - lipegfilgrastim - injection, solution - lipegfilgrastim 6.00 mg/0.6ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
lonquex 6mg0.6ml solution for injection pre-filled syringes
teva uk ltd - lipegfilgrastim - solution for injection - 10mg/1ml